Association between serum estradiol level on the human chorionic gonadotrophin administration day and clinical outcome

Abstract. Background:. Estradiol, as an important hormone in follicular development and endometrial receptivity, is closely related to clinical outcomes of fresh in vitro fertilization embryo transfer (IVF-ET) cycles. The aim of this retrospective study was to evaluate the association between elevat...

Full description

Bibliographic Details
Main Authors: Xin Li, Cheng Zeng, Jing Shang, Sheng Wang, Xue-Lian Gao, Qing Xue, Li-Min Chen
Format: Article
Language:English
Published: Wolters Kluwer 2019-05-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000000251
id doaj-c9a04dfdfa6b4f7592e526d22d751adb
record_format Article
spelling doaj-c9a04dfdfa6b4f7592e526d22d751adb2020-12-02T07:47:35ZengWolters KluwerChinese Medical Journal0366-69992542-56412019-05-01132101194120110.1097/CM9.0000000000000251201905200-00010Association between serum estradiol level on the human chorionic gonadotrophin administration day and clinical outcomeXin Li0Cheng Zeng1Jing Shang2Sheng Wang3Xue-Lian Gao4Qing Xue5Li-Min Chen6Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China.Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China.Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China.Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China.Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China.Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China.Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China.Abstract. Background:. Estradiol, as an important hormone in follicular development and endometrial receptivity, is closely related to clinical outcomes of fresh in vitro fertilization embryo transfer (IVF-ET) cycles. The aim of this retrospective study was to evaluate the association between elevated serum estradiol (E2) levels on the day of human chorionic gonadotrophin (hCG) administration and IVF-ET pregnancy and birth outcomes. Methods:. A total of 1771 infertile patients with their first fresh IVF-ET cycles were analyzed retrospectively between January 2011 and January 2016 in Peking University First Hospital. Patients were categorized by serum E2 levels on the day of hCG administration into six groups: group 1 (serum E2 levels ≤ 1000 pg/mL, n = 205), group 2 (serum E2 levels 1001–2000 pg/mL, n = 457), group 3 (serum E2 levels 2001–3000 pg/mL, n = 425), group 4 (serum E2 levels 3001–4000 pg/mL, n = 310), group 5 (serum E2 levels 4001–5000 pg/mL, n = 237), and group 6 (serum E2 levels > 5000 pg/mL, n = 137). The retrieved oocyte and MII oocyte numbers and implantation and clinical pregnancy rates of the groups were compared as the first objective of the study. For the 360 women with singleton births among all patients, the area under the corresponding receiver operating characteristic curve (ROC curve) was calculated to assess the predictive value of the E2 change for the probability of low birth weight (LBW) infants as the second objective. Results:. The retrieved oocyte and MII oocyte numbers and implantation and clinical pregnancy rates gradually increased from groups 1 to 5 but decreased in group 6. The parameters of group 1 were statistically worse than those of the other groups, from group 2 to group 6 (the number of retrieved oocytes, t = 13.096, t = 23.307, t = 23.086, t = 26.376, t = 19.636, P < 0.003; the number of retrieved MII oocytes, t = 10.856, t = 20.868, t = 21.874, t = 23.374, t = 19.092, P < 0.003; the implantation rate, χ2 = 12.179, χ2 = 22.239, χ2 = 23.993, χ2 = 23.344, χ2 = 16.758, P < 0.003; the clinical pregnancy rate, χ2 = 16.415, χ2 = 28.074, χ2 = 35.387, χ2 = 37.025, χ2 = 24.590, P < 0.003). ROC analysis revealed that when a serum peak E2 of 3148 pg/mL was used to predict LBW. Conclusions:. The results indicate that serum E2 levels have a concentration-dependent effect on clinical outcomes. The optimal range of the E2 level during a fresh IVF-ET cycle is 1000 to 3148 pg/mL.http://journals.lww.com/10.1097/CM9.0000000000000251
collection DOAJ
language English
format Article
sources DOAJ
author Xin Li
Cheng Zeng
Jing Shang
Sheng Wang
Xue-Lian Gao
Qing Xue
Li-Min Chen
spellingShingle Xin Li
Cheng Zeng
Jing Shang
Sheng Wang
Xue-Lian Gao
Qing Xue
Li-Min Chen
Association between serum estradiol level on the human chorionic gonadotrophin administration day and clinical outcome
Chinese Medical Journal
author_facet Xin Li
Cheng Zeng
Jing Shang
Sheng Wang
Xue-Lian Gao
Qing Xue
Li-Min Chen
author_sort Xin Li
title Association between serum estradiol level on the human chorionic gonadotrophin administration day and clinical outcome
title_short Association between serum estradiol level on the human chorionic gonadotrophin administration day and clinical outcome
title_full Association between serum estradiol level on the human chorionic gonadotrophin administration day and clinical outcome
title_fullStr Association between serum estradiol level on the human chorionic gonadotrophin administration day and clinical outcome
title_full_unstemmed Association between serum estradiol level on the human chorionic gonadotrophin administration day and clinical outcome
title_sort association between serum estradiol level on the human chorionic gonadotrophin administration day and clinical outcome
publisher Wolters Kluwer
series Chinese Medical Journal
issn 0366-6999
2542-5641
publishDate 2019-05-01
description Abstract. Background:. Estradiol, as an important hormone in follicular development and endometrial receptivity, is closely related to clinical outcomes of fresh in vitro fertilization embryo transfer (IVF-ET) cycles. The aim of this retrospective study was to evaluate the association between elevated serum estradiol (E2) levels on the day of human chorionic gonadotrophin (hCG) administration and IVF-ET pregnancy and birth outcomes. Methods:. A total of 1771 infertile patients with their first fresh IVF-ET cycles were analyzed retrospectively between January 2011 and January 2016 in Peking University First Hospital. Patients were categorized by serum E2 levels on the day of hCG administration into six groups: group 1 (serum E2 levels ≤ 1000 pg/mL, n = 205), group 2 (serum E2 levels 1001–2000 pg/mL, n = 457), group 3 (serum E2 levels 2001–3000 pg/mL, n = 425), group 4 (serum E2 levels 3001–4000 pg/mL, n = 310), group 5 (serum E2 levels 4001–5000 pg/mL, n = 237), and group 6 (serum E2 levels > 5000 pg/mL, n = 137). The retrieved oocyte and MII oocyte numbers and implantation and clinical pregnancy rates of the groups were compared as the first objective of the study. For the 360 women with singleton births among all patients, the area under the corresponding receiver operating characteristic curve (ROC curve) was calculated to assess the predictive value of the E2 change for the probability of low birth weight (LBW) infants as the second objective. Results:. The retrieved oocyte and MII oocyte numbers and implantation and clinical pregnancy rates gradually increased from groups 1 to 5 but decreased in group 6. The parameters of group 1 were statistically worse than those of the other groups, from group 2 to group 6 (the number of retrieved oocytes, t = 13.096, t = 23.307, t = 23.086, t = 26.376, t = 19.636, P < 0.003; the number of retrieved MII oocytes, t = 10.856, t = 20.868, t = 21.874, t = 23.374, t = 19.092, P < 0.003; the implantation rate, χ2 = 12.179, χ2 = 22.239, χ2 = 23.993, χ2 = 23.344, χ2 = 16.758, P < 0.003; the clinical pregnancy rate, χ2 = 16.415, χ2 = 28.074, χ2 = 35.387, χ2 = 37.025, χ2 = 24.590, P < 0.003). ROC analysis revealed that when a serum peak E2 of 3148 pg/mL was used to predict LBW. Conclusions:. The results indicate that serum E2 levels have a concentration-dependent effect on clinical outcomes. The optimal range of the E2 level during a fresh IVF-ET cycle is 1000 to 3148 pg/mL.
url http://journals.lww.com/10.1097/CM9.0000000000000251
work_keys_str_mv AT xinli associationbetweenserumestradiollevelonthehumanchorionicgonadotrophinadministrationdayandclinicaloutcome
AT chengzeng associationbetweenserumestradiollevelonthehumanchorionicgonadotrophinadministrationdayandclinicaloutcome
AT jingshang associationbetweenserumestradiollevelonthehumanchorionicgonadotrophinadministrationdayandclinicaloutcome
AT shengwang associationbetweenserumestradiollevelonthehumanchorionicgonadotrophinadministrationdayandclinicaloutcome
AT xueliangao associationbetweenserumestradiollevelonthehumanchorionicgonadotrophinadministrationdayandclinicaloutcome
AT qingxue associationbetweenserumestradiollevelonthehumanchorionicgonadotrophinadministrationdayandclinicaloutcome
AT liminchen associationbetweenserumestradiollevelonthehumanchorionicgonadotrophinadministrationdayandclinicaloutcome
_version_ 1724408162948218880